|
MEN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78719999805099E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.2305999999972E-05 |
| Normal-vs-Stage2 |
5.646300E-02 |
| Normal-vs-Stage3 |
8.844200E-03 |
| Normal-vs-Stage4 |
1.744020E-01 |
| Stage1-vs-Stage2 |
9.017800E-01 |
| Stage1-vs-Stage3 |
4.307400E-01 |
| Stage1-vs-Stage4 |
7.240000E-01 |
| Stage2-vs-Stage3 |
5.696200E-01 |
| Stage2-vs-Stage4 |
7.543400E-01 |
| Stage3-vs-Stage4 |
9.078800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38820000050721E-07 |
| Normal-vs-AfricanAmerican |
2.751600E-04 |
| Normal-vs-Asian |
2.918400E-01 |
| Caucasian-vs-AfricanAmerican |
6.163200E-01 |
| Caucasian-vs-Asian |
8.326200E-01 |
| AfricanAmerican-vs-Asian |
9.643200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.15199999948391E-07 |
| Normal-vs-Female |
4.33349999995336E-07 |
| Male-vs-Female |
9.902000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.165500E-04 |
| Normal-vs-Extreme_Weight |
4.698900E-03 |
| Normal-vs-Obese |
2.14060000000016E-05 |
| Normal-vs-Extreme_Obese |
9.199800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.738960E-01 |
| Normal_Weight-vs-Obese |
7.328000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.431600E-01 |
| Extreme_Weight-vs-Obese |
5.828100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.591600E-01 |
| Obese-vs-Extreme_Obese |
5.965400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.58360000000513E-05 |
| Normal-vs-Age(41-60Yrs) |
2.22670000216141E-08 |
| Normal-vs-Age(61-80Yrs) |
3.51550000000644E-05 |
| Normal-vs-Age(81-100Yrs) |
6.858600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.058200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.906000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.583500E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.366230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.517000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.761600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.62929711126026E-11 |
| Normal-VS-Type2 PRCC |
9.217400E-01 |
| Normal-VS-KIRP CIMP |
1.001590E-03 |
| Normal-VS-Unclassified PRCC |
4.591900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.35879998761379E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.151670E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.573600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.8811000000184E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
6.440200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.592210E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.051800E-02 |
| Normal-vs-N1 |
4.937600E-03 |
| Normal-vs-N2 |
7.518800E-01 |
| N0-vs-N1 |
8.536300E-02 |
| N0-vs-N2 |
9.944800E-01 |
| N1-vs-N2 |
5.081200E-01 |
|
|
